Last week, two new publications on Pharmacotherapy-Online were released. One publication discusses the pathophysiology, diagnosis and treatment of axial spondyloarthritis and the other one discusses rheumatoid arthritis. These articles were published in Dutch.
Spondyloarthritis (SpA) is an umbrella term for a number of inflammatory rheumatic diseases of the musculoskeletal system with related clinical characteristics, genetic predisposition and familial occurrence. The treatment of SpA improved considerably in recent years. In addition to non-medical support such as exercise therapy, NSAIDs are the most important treatment strategy. When patients show no or insufficient response to NSAIDs, they are eligible for treatment with a TNF-α inhibitor.
Medical treatment options for rheumatoid arthritis (RA) have also improved considerably during the last decades. The four main pillars of modern RA treatment are early intervention, combination therapy, monitoring strategies and biologicals. This Pharmacotherapy-Online publication discusses the treatment of RA and the factors that contribute to the achievement of these treatment goals. These factors include choice of medication, precision- and personalized medicine, shared decision making and adherence to therapy. Cost effectiveness and participation of the patient are also discussed.